Part Details | THEOPHYLLINE EXTENDED-RELEASE TABLETS
6505-01-073-1552
Alternate Parts: NDC00677081701, NDC00677-0817-01, NDC00456433001, NDC00456-4330-01, NDC00603594621, NDC00603-5946-21, NDC00258358101, NDC00258-3581-01, NDC00182140089, NDC00182-1400-89, THEODUR, THEO-DUR, NDC00369080381, NDC00369-0803-81, NDC00904161261, NDC00904-1612-61, NDC61570001901, NDC61570-0019-01, NDC50111045901, NDC50111-0459-01, THEODUR, THEO-DUR, NDC00085058481, NDC00085-0584-81, 6505-01-073-1552, 01-073-1552, 6505010731552, 010731552
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | MAR 10, 1979 | 01-073-1552 | 42612 ( THEOPHYLLINE EXTENDED-RELEASE TABLETS ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-073-1552
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00677-0817-01 | 59225 | BAXTER HEALTHCARE CORPBAXTER AIRLIFE/PHARMASEAL DIV |
| NDC00456-4330-01 | 65050 | FOREST PHARMACEUTICALS INCSUB OF FOREST LABORATORIES INC |
| NDC00603-5946-21 | 0ET99 | GENERICS BIDCO I, LLCDBA PAR PHARMACEUTICAL |
| NDC00258-3581-01 | 6X308 | INWOOD LABORATORIES INC |
| NDC00182-1400-89 | 0LXM4 | IVAX |
| THEO-DUR | 24214 | KEY PHARMACEUTICALS INC |
| NDC00369-0803-81 | 24214 | KEY PHARMACEUTICALS INC |
| NDC00904-1612-61 | 0SYT3 | MAJOR PHARMACEUTICALS INC |
| NDC61570-0019-01 | 09GL2 | MONARCH PHARMACEUTICALS INC |
| NDC50111-0459-01 | 3PYX2 | PLIVA INC. |
| THEO-DUR | 1F095 | SCHERING-PLOUGH CORPORATION |
| NDC00085-0584-81 | 1F095 | SCHERING-PLOUGH CORPORATION |
Technical Data | NSN 6505-01-073-1552
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB300.000 MILLIGRAMS THEOPHYLLINE |
| PRIMARY CONTAINER TYPE | STRIP |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| FEATURES PROVIDED | UNIT DOSE |
| THERAPEUTIC EQUIVALENT | THEO-DUR BY KEY PHARM |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG I.S. 100S PG |